Colon Cancer Screening Update and Management of the Malignant Polyp

ABSTRACT

Colorectal carcinoma is common, but screening for this cancer has found less acceptance with the public than screening for breast, prostate, and cervical cancer. Available methods include fecal occult blood tests (FOBTs), flexible sigmoidoscopy (FOS), double-contrast barium enema, colonoscopy, computed tomographic colography, and fecal DNA. Evaluation of these options demonstrates that colonoscopy at ages 55 and 65 offers the best combination of reduction in colorectal cancer at the lowest cost. However, when compliance with screening recommendations is very high, costs are high, and the proportion of cancers arising from adenomas is low, the combination of FOS and FOBT is most cost effective. Malignant polyps look friable and irregular and feel hard. Sessile malignant polyps need to be treated by formal resection. Patients with pedunculated polyps with favorable histology (clear margin, well or moderately differentiated, no lymphovascular invasion) can be observed, and those whose polyps show unfavorable histology should have the polyp-bearing segment of colon resected along with its draining lymph nodes.

KEYWORDS

Colorectal cancer screening - colonoscopy - malignant polyp - histology

REFERENCES

• 1 Church J M, Casey G. Molecular Genetics and Colorectal Neoplasia: A Primer for the Clinician. 2nd ed. New York, NY; Kluwer Academic Publishers 2003
• 2 Jernal A, Murray T, Ward E et al.. Cancer statistics 2005. Ca; a Cancer Journal for Clinicians 2005 55: 10-30
• 3 Winawer S J, Zauber A G, O'Brien M J et al.. Prevention of colorectal cancer by colonoscopic polypectomy.  N Engl J Med. 1993;  329 1977-1981
• 4 Ries L, Wingo P A, Miller D S et al.. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer.  Cancer. 2000;  88 2398-2424
• 5 Cram P, Fendirick A, Inadomi J, Cowen M, Carpenter D, Vijan S. The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect.  Arch Intern Med. 2003;  163 1601-1605
• 6 Pickhardt P J, Choi J R, Hwang I et al.. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults.  N Engl J Med. 2003;  349 2191-2200
• 7 Cotton P B, Durkalski V L, Pineau B C et al.. Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia.  JAMA. 2004;  291 1713-1719
• 8 Imperiale T F, Ransohoff D F, Itzkowitz S H, Turnbull B A, Ross M E. Colorectal Cancer Study Group. . Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.  N Engl J Med. 2004;  351 2704-2714
• 9 Lejeune C, Arveux P, Dancourt V, Bejean S, Bonithon-Kopp C, Faivre J. Cost-effectiveness analysis of fecal occult blood screening for colorectal cancer.  Int J Technol Assess Health Care. 2004;  20 434-439
• 10 Sonnenberg A, Delco F, Inadomi J M. Cost-effectiveness of colonoscopy in screening for colorectal cancer.  Ann Intern Med. 2000;  133 573-584
• 11 Chorost M, Datta R, Santiago R et al.. Colon cancer screening: where have we come from and where do we go?.  J Surg Oncol. 2004;  85 7-13
• 12 Mandel J S, Bond J H, Church T R et al.. Reducing mortality from colorectal cancer for fecal occult blood: Minnesota Colon Cancer Control Study.  N Engl J Med. 1993;  328 1365-1371
• 13 Hardcastle J D, Thomas W M, Chamberlain J et al.. Randomized, controlled trial of faecal occult blood screening for colorectal cancer.  Lancet. 1996;  348 1472-1477
• 14 Kronborg O, Fenger C, Olsen J et al.. Randomized study of screening for colorectal cancer with faecal-occult blood test.  Lancet. 1996;  348 1467-1471
• 15 Lieberman D A, Weiss D G. One-time screening for colorectal cancer with combined fecal-occult blood testing and examination of the distal colon.  N Engl J Med. 2001;  345 555-560
• 16 Church J M. A scoring system for the strength of a family history of colorectal cancer.  Dis Colon Rectum. 2005;  48 889-896
• 17 Church J, Lowry A, Simmang C et al.. Practice parameters for the identification and testing of patients at risk for dominantly inherited colorectal cancer-supporting documentation.  Dis Colon Rectum. 2001;  44 1404-1412
• 18 Atkin W S, Morson B C, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas.  N Engl J Med. 1992;  326 658-662
• 19 Lashner B. Colorectal cancer surveillance for patients with inflammatory bowel disease.  Gastrointest Endosc Clin N Am. 2002;  12 135-143
• 20 Vijan S, Hwang E, Hofer T, Hayward R. Which colon cancer screening test? A comparison of costs, effectiveness and compliance.  Am J Med. 2001;  111 593-601
• 21 Selby J V, Friedman G D, Queensberry Jr C P et al.. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer.  N Engl J Med. 1992;  326 653-657
• 22 Lieberman D A, Weiss D G, Bond J H et al.. Use of colonoscopy to screen asymptomatic adults for colorectal cancer.  N Engl J Med. 2000;  343 162-168
• 23 Podolsky D K. Going the distance: the case for true colorectal cancer screening.  N Engl J Med. 2000;  343 207-208
• 24 Fork F T. Double contrast enema and colonoscopy in polyp detection.  Gut. 1981;  22 971-977
• 25 Hixson L J, Fennerty M B, Samliner R E et al.. Prospective study of the frequency and size distribution of polyps missed by colonoscopy.  J Natl Cancer Inst. 1990;  82 1769-1772
• 26 Rex D K, Rahmani E Y, Haseman J H, Lemmel G T, Kaster S, Buckley J S. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice.  Gastroenterology. 1997;  112 17-23
• 27 Winawer S, Stewart E T, Zauber A G et al.. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy.  N Engl J Med. 2000;  342 1766-1772
• 28 Detsky A. Screening for colon cancer-can we afford colonoscopy?.  N Engl J Med. 2001;  345 607-608
• 29 Hull T, Church J M. Colonoscopy: how difficult, how painful?.  Surg Endosc. 1994;  8 784-787
• 30 Church J. Complications in colonoscopy. In: Waye J Colonoscopy: Principles and Practice. Malden, MA; Blackwell Publishing 2004: 170-182
• 31 Church J M. Endoscopy of the Colon, Rectum, and Anus. New York; Igaku-Shoin 1995
• 32 Bell C M, Crystal M, Detsky A S, Pansegrau G K. Charges for medical care at different hospitals.  Arch Intern Med. 2000;  160 1417-1422
• 33 Frazier A L, Colditz G A, Fuchs C S, Kuntz K M. Cost-effectiveness of screening for colorectal cancer in the general population.  JAMA. 2000;  284 1954-1961
• 34 Seeff L C, Richards T B, Shapiro J A et al.. How many endoscopies are performed for colorectal cancer screening? Results from CDC's survey of endoscopic capacity.  Gastroenterology. 2004;  127 1670-1677
• 35 Seeff L C, Manninen D L, Dong F B et al.. Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States?.  Gastroenterology. 2004;  127 1661-1669
• 36 Ferrucci J T. Virtual colonoscopy for colon cancer screening: further reflections on polyps and politics.  AJR Am J Roentgenol. 2003;  181 795-797
• 37 Church J M. Clinical significance of small colorectal polyps.  Dis Colon Rectum. 2004;  47 481-485
• 38 Anderson L M, May D S. Has the use of cervical, breast and colorectal cancer screening increased in the United States?.  Am J Public Health. 1995;  85 840-843
• 39 Rossi S C, Srivastava S. National Cancer Institute workshop on genetic screening for colorectal cancer.  J Natl Cancer Inst. 1996;  88 331-339
• 40 Komuta K, Batts K, Jessurun J et al.. Interobserver variability in the pathological assessment of malignant colorectal polyps.  Br J Surg. 2004;  91 1479-1484
• 41 Rex D K, Alikhan M, Cummings O, Ulbright T M. Accuracy of pathologic interpretation of colorectal polyps by general pathologists in community practice.  Gastrointest Endosc. 1999;  50 468-474
• 42 Church J M. Endoscopy of the Colon Rectum and Anus. New York; Igaku-Shoin 1995
• 43 Haggitt R C, Glotzbach R E, Soffer E E et al.. Prognostic factors in colorectal carcinomas arising in adenomas: implications for lesions removed by endoscopic polypectomy.  Gastroenterology. 1985;  89 328-336
• 44 Volk E E, Goldblum J R, Petras R E, Carey W D, Fazio V W. Management and outcome of patients with invasive carcinoma arising in colorectal polyps.  Gastroenterology. 1995;  109 1801-1807
• 45 Netzer P, Forster C, Biral R et al.. Risk factor assessment of endoscopically removed malignant colorectal polyps.  Gut. 1998;  43 669-674
• 46 Cooper H S, Deppisch L M, Gourley W K et al.. Endoscopically removed malignant colorectal polyps: clinicopathologic correlations.  Gastroenterology. 1995;  108 1657-1665
• 47 Hackelsberger A, Fruhmorgen P, Weiler H, Heller T, Seeliger H, Junghanns K. Endoscopic polypectomy and management of colorectal adenomas with invasive carcinoma.  Endoscopy. 1995;  27 153-158
• 48 Seitz U, Bohnacker S, Seewald S et al.. Is endoscopic polypectomy an adequate therapy for malignant colorectal adenomas? Presentation of 114 patients and review of the literature.  Dis Colon Rectum. 2004;  47 1789-1796
• 49 Clinical Outcomes of Surgical Therapy Study Group . A comparison of laparoscopically assisted and open colectomy for colon cancer.  N Engl J Med. 2004;  350 2050-2059
• 50 Tekkis P P, Poloniecki J D, Thompson M R, Stamatakis J D. Operative mortality in colorectal cancer: prospective national study.  BMJ. 2003;  327 1196-1201
• 51 Vignali A, Fazio V W, Lavery I C et al.. Factors associated with the occurrence of leaks in stapled rectal anastomoses: a review of 1,014 patients.  J Am Coll Surg. 1997;  185 105-113